基于数量采购 (VBP) 政策下的心血管药物消费增加:需求释放还是评估诱导?
Ying Yang1, Jieming Zhang2, Yuanhui Duan1
1School of Nursing, Tongji Medical College, Huazhong University of Science and Technology, No. 13, Hangkong Road, Wuhan, 430030, China.
Health research policy and systems
|December 2, 2024
概括
国家基于数量的采购 (VBP) 政策通过改善低收入群体的获取和通过对医院的政策压力,增加了心血管药物消费. 这些发现突出了推动药物使用的双重机制,推动了VBP后的实施.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 公共卫生 公共卫生
背景情况:
- 国家基于数量的采购 (VBP) 政策的实施与药物消费的增加相吻合,促使对需求释放和政策诱导的影响进行调查.
- 了解VBP下毒品消费增长的驱动因素对于有效的医疗保健政策和资源配置至关重要.
研究的目的:
- 探索国家基于数量的采购 (VBP) 政策实施后毒品消费增加背后的原因和机制.
- 要区分需求释放 (未满足的需求) 和政策诱导的消费 (潜在的过度处方).
主要方法:
- 利用来自中国药品供应信息平台,国家统计局和联合采购办公室的数据.
- 在418个INN地区的心血管药物组合中,从前三批VBP中采用了通用差异差异方法.
- 检查了居民收入水平在降价和毒品消费之间的关系中所起的调节作用.
主要成果:
- 心血管药物消费在VBP后的INN区域组合中增加了68.18%.
- 价格下降与消费增加有显著的相关性,特别是受益于低收入群体和初级医疗保健中心.
- 政策评估任务与药物消费积极相关,表明潜在的过度处方激励措施.
结论:
- VBP政策通过改善低收入人群的药物获取和政策驱动的医院处方压力来推动药物消费的增加.
- 研究结果表明,VBP满足未满足的心血管药物需求,同时也可能导致由于评估措施导致过度处方.
相关概念视频
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
Regulation of Stroke Volume
3.1K
The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
3.1K
Pathophysiology of Cardiac Performance
557
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
557
Heart Failure Drugs: β-Blockers
316
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
316
Drug Control Governance: Regulatory Bodies and Their Impact
141
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
141
Pharmacovigilance
773
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
773


